Sign in
4

Changes in Ownership

Traws Pharma, Inc. Filed Acc 0001415889-22-008260

CHIEF MEDICAL OFFICER gave up 1,135 shares (to pay taxes)

  • CHIEF MEDICAL OFFICER acquired 4,650 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Gelder Mark S. MD CHIEF MEDICAL OFFICER 2022-08-02 Option exercise +4,650 7,031 D
Gelder Mark S. MD CHIEF MEDICAL OFFICER 2022-08-03 Shares withheld for taxes −1,135 $1.32 $1,498 5,896 D
Derivatives
Gelder Mark S. MD CHIEF MEDICAL OFFICER 2022-08-02 Option exercise · Restricted Stock Units −4,650 9,300 D
Loading xslF345X03/form4-08042022_010823.xml…